9906 — Honliv Healthcare Management Co Income Statement
0.000.00%
Last trade - 00:00
- HK$1.51bn
- HK$1.45bn
- CNY760.53m
- 74
- 32
- 72
- 66
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 531 | 524 | 607 | 728 | 761 |
Cost of Revenue | |||||
Gross Profit | 170 | 138 | 135 | 138 | 145 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 435 | 462 | 540 | 666 | 703 |
Operating Profit | 96.5 | 62 | 66.6 | 61.6 | 57.4 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 68.5 | 30.9 | 50.5 | 63 | 51.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | 49.9 | 22.2 | 37 | 49.3 | 38.7 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 49.4 | 21.8 | 36.6 | 48.9 | 38.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 49.4 | 21.8 | 36.6 | 48.9 | 38.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.146 | 0.064 | 0.061 | 0.089 | 0.085 |